›› 2010, Vol. 5 ›› Issue (6): 203-211.

• Reviews •     Next Articles

Gender differences in the bioavailability and pharmacokinetics of γ-schisandrin from a Wurenchun-PVP k30 solid dispersion in rats

Tie Zhao 1; Mingfeng Qiu 1 *; Guoxiang Xie 2; Hongbing Wu 1; Wei Jia 2
  

  1. 1. School of Pharmacy, Shanghai Jiao Tong University, Shanghai 200240, China 2. Department of Nutrition, University of North Carolina at Greensboro, North Carolina Research Campus, Kannapolis, NC 28081, USA
  • Received:2010-07-03 Revised:2010-11-10 Online:2010-12-20 Published:2010-12-20
  • Contact: Mingfeng Qiu

Abstract: γ-Schisandrin, as one of main active components in Wurenchun, has a very low solubility in water and requires large doses to be effective. The aim of this study was to evaluate the pharmacokinetics and bioavailability of γ-schisandrin from a Wurenchun-PVP k30 solid dispersion (WSD) and conventional self-prepared capsules (CSP). A selective, accurate and simple high performance liquid chromatography (HPLC) method was established and the plasma concentration profiles and pharmacokinetic parameters of γ-schisandrin in rats were investigated after oral administration of WSD and CSP. The results revealed that the bioavailability of γ-schisandrin in rats administrated WSD increased significantly compared with the CSP. The pharmacokinetic results of γ-schisandrin in rats after i.g. WSD or CSP demonstrated the existence of marked gender-dependent differences. The Cmax and AUC values of γ-schisandrin in female rats after i.g. WSD and CSP were found to be about 3-fold and 6-fold higher, respectively, than those in male rats. This gender difference could be helpful in determining the appropriate dosage of WSD and its preparations.

Key words: pharmacokinetics, bioavailability, γ-schisandrin, solid dispersion, gender difference.

Trendmd